Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web‐based survey by the European Network of Uropathology
暂无分享,去创建一个
D. Berney | G. Kristiansen | T. H. van der Kwast | J. Oxley | M. Varma | L. Egevad | L. Bubendorf | E. Compérat | O. Hes | G. V. van Leenders | S. Prendeville
[1] A. Haese*,et al. Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer. , 2018, European urology.
[2] N. Lawrentschuk,et al. Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer , 2018, Nature Reviews Urology.
[3] Lili Zhao,et al. High Variability in Lymph Node Counts Among an International Cohort of Pathologists: Questioning the Scientific Validity of Node Counts. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.
[4] E. Compérat,et al. Microbiota: Bacteriophage diversity in the urinary microbiome , 2018, Nature Reviews Urology.
[5] H. G. van der Poel,et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. , 2017, European urology.
[6] C. Compton,et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.
[7] Mark W. Ball,et al. Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series , 2017, BJU international.
[8] S. Rais-Bahrami,et al. Complete Tissue Submission to Increase Lymph Node Detection in Pelvic Lymph Node Packets Submitted for Patients Undergoing Radical Prostatectomy and Radical Cystectomy , 2017, International journal of surgical pathology.
[9] T. H. van der Kwast,et al. Lymph node staging in prostate cancer: perspective for the pathologist , 2016, Journal of Clinical Pathology.
[10] Anirban P. Mitra,et al. Radical cystectomy with super‐extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes , 2016, BJU international.
[11] H. S. Kim,et al. Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis , 2015, BMC Cancer.
[12] M. Varma,et al. Effective maybe, but is it cost‐effective? , 2015, Histopathology.
[13] J. Witjes,et al. The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. , 2014, European urology.
[14] F. Montorsi,et al. Total submission of lymphadenectomy tissues removed during radical prostatectomy for prostate cancer: possible clinical significance of large-format histology. , 2014, Human pathology.
[15] J. Witjes,et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. , 2014, European urology.
[16] B. Delahunt,et al. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases , 2014, Histopathology.
[17] Y. Lotan,et al. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. , 2013, European urology.
[18] B. Trock,et al. Comparison of Biochemical Recurrence–Free Survival Between Periprostatic and Pelvic Lymph Node Metastases of Prostate Cancer , 2013, International journal of surgical pathology.
[19] K. Sotlar,et al. Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost‐benefit analysis , 2012, BJU international.
[20] F. Montorsi,et al. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer , 2012, International journal of urology : official journal of the Japanese Urological Association.
[21] M. Menon,et al. Characteristics of Pelvic Lymph Node Metastases in Prostatic Adenocarcinoma , 2012, International journal of surgical pathology.
[22] S. Mendrinos,et al. Periprostatic lymph node metastasis in prostate cancer and its clinical significance , 2012, Histopathology.
[23] J. Hecht. To count and how to count, that is the question. , 2011, American journal of clinical pathology.
[24] C. Stief,et al. Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy , 2011, Annals of Surgical Oncology.
[25] J. Concato,et al. To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting. , 2010, American journal of clinical pathology.
[26] A. Renshaw,et al. Protocol for the examination of specimens from patients with carcinoma of the prostate gland. , 2009, Archives of pathology & laboratory medicine.
[27] P. Verhagen,et al. Histopathological characteristics of lymph node metastases predict cancer‐specific survival in node‐positive prostate cancer , 2008, BJU international.
[28] F. Burkhard,et al. Prognostic factors in lymph node metastases of prostatic cancer patients: the size of the metastases but not extranodal extension independently predicts survival , 2008, Histopathology.
[29] E. Klein,et al. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. , 2008, Journal of Urology.
[30] Badrinath R Konety,et al. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. , 2003, The Journal of urology.
[31] F. Wawroschek,et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. , 2003, European urology.
[32] V. Reuter,et al. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. , 2001, The Journal of urology.
[33] M. Kattan,et al. Incidence, Location, and Significance of Periprostatic and Periseminal Vesicle Lymph Nodes in Prostate Cancer , 2001, The American journal of surgical pathology.
[34] J. Thüroff,et al. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis , 2000, BJU international.
[35] M. Banerjee,et al. Lymph node size does not correlate with the presence of prostate cancer metastasis. , 1999, Urology.
[36] J. Cheville,et al. Cancer volume of lymph node metastasis predicts progression in prostate cancer. , 1998, The American journal of surgical pathology.
[37] A. Ramaswamy,et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. , 1996, The Journal of urology.
[38] N. Marcussen,et al. Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases , 2013, Virchows Archiv.
[39] Sarah J. Johnson,et al. Standards and datasets for reporting cancers , 2013 .
[40] B. Delahunt,et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes , 2011, Modern Pathology.
[41] F. Montorsi,et al. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. , 2007, Urology.
[42] P. Barth,et al. The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer. , 1999, Pathology, research and practice.
[43] Standards and datasets for reporting cancers Dataset for histopathology reports for prostatic carcinoma June 2016 , 2022 .